DarioHealth Wins Fifth Fortune 50 Employer Contract
NEW YORK, July 16, 2026 DarioHealth Corp. has secured a major commercial milestone after being selected by another Fortune...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
NEW YORK, July 16, 2026 DarioHealth Corp. has secured a major commercial milestone after being selected by another Fortune...
TAMPA, Fla., July 16, 2026 Inspirata AI has officially unveiled its new corporate identity, transitioning from Inspirata to Inspirata...
